NOVEL DIAGNOSTIC METHOD FOR DIAGNOSING DEPRESSION AND MONITORING THERAPY EFFECTIVENESS

摘要

The present invention relates to a method of diagnosing or monitoring the progression of a mood disorder, by assaying the level of lipocalin-2 in the body fluid of a subject. Preferably said mood disorder is depression, chosen from dysthymia, endogenous depression, minor depression, major depression, psychotic depression, neurotic depression, postnatal depression, burn out, overstrain, unipolar depression and bipolar depression. Also a combined detection of lipocalin-2 and BDNF for the method according to the invention is proposed.